Interventions to restore appropriate immune function in the elderly

Immunity and Ageing

Volumn 15, Issue 1, 2018, Pages

  Aspinall, Richard ^a,c   Lang, Pierre Olivier ^b,c  

^a Rivock Ltd   (United Kingdom)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; RAPAMYCIN; RECOMBINANT KERATINOCYTE GROWTH FACTOR; VARICELLA ZOSTER VACCINE;

ADOPTIVE TRANSFER; AGED; BLOOD TRANSFUSION; CASTRATION; CHEMICAL CASTRATION; CLINICAL OBSERVATION; COST EFFECTIVENESS ANALYSIS; DRUG RESPONSE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL PROCEDURES; IMMUNOPATHOLOGY; IMMUNOSENESCENCE; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INNATE IMMUNITY; NONHUMAN; NUTRITION; PATIENT IDENTIFICATION; PRIORITY JOURNAL; REJUVENATION; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VACCINATION;

EID: 85041462645     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/s12979-017-0111-6     Document Type: Review

References (77)

1. Fulop T, et al. Aging, frailty and age-related diseases. Biogerontology. 2010;11:547-63. https://doi.org/10.1007/s10522-010-9287-2.
2. Lang PO, Mitchell WA, Lapenna A, Pitts D, Aspinall R. Immunological pathogenesis of main aged-related disease and frailty: role of immunosenescence. Eur Geriatric Med. 2010;1:9.
3. Cliff A, Haggett P. Time, travel and infection. Br Med Bull. 2004;69:87-99. https://doi.org/10.1093/bmb/ldh011.
4. Lang, P. O., Loulergue, P. & Aspinall, R. Chikungunya Virus Infection: Why Should U.S. Geriatricians Be Aware of It? J Am Geriatr Soc. 2017. https://doi.org/10.1111/jgs.15104.
5. Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2017; https://doi.org/10.1111/resp.13196.
6. Aspinall R, Lang PO. Vaccination choices for older people, looking beyond age specific approaches. Expert Rev Vaccines. 2018;17:23-30. https://doi.org/10.1080/14760584.2018.1411197.
7. Lang PO, Trivalle C, Vogel T, Proust J, Papazian JP. Markers of metabolic and cardiovascular health in adults: comparative analysis of DEXA-based body composition components and BMI categories. J Cardiol. 2015;65:42-9. https://doi.org/10.1016/j.jjcc.2014.03.010.
8. Lang PO, et al. Is obesity a marker of robustness in vulnerable hospitalized aged populations? Prospective, multicenter cohort study of 1 306 acutely ill patients. J Nutr Health Aging. 2014;18:66-74. https://doi.org/10.1007/s12603-013-0352-9.
9. Dixit VD. Thymic fatness and approaches to enhance thymopoietic fitness in aging. Curr Opin Immunol. 2010;22:521-8. https://doi.org/10.1016/j.coi.2010.06.010.
10. Yang H, et al. Obesity accelerates thymic aging. Blood. 2009;114:3803-12. https://doi.org/10.1182/blood-2009-03-213595.
11. Yang H, Youm YH, Dixit VD. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution. J Immunol. 2009;183:3040-52. https://doi.org/10.4049/jimmunol.0900562.
12. Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol. 2009;9:185-94. https://doi.org/10.1038/nri2508.
13. Bharath LP, Ip BC, Nikolajczyk BS. Adaptive immunity and metabolic health: harmony becomes dissonant in obesity and aging. Compr Physiol. 2017;7:1307-37. https://doi.org/10.1002/cphy.c160042.
14. Choi CHJ, Cohen P. Adipose crosstalk with other cell types in health and disease. Exp Cell Res. 2017;360:6-11. https://doi.org/10.1016/j.yexcr.2017.04.022.
15. Calder PC, et al. Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Res Rev. 2017;40:95-119. https://doi.org/10.1016/j.arr.2017.09.001.
16. Johnson MO, Siska PJ, Contreras DC, Rathmell JC. Nutrients and the microenvironment to feed a T cell army. Semin Immunol. 2016;28:505-13. https://doi.org/10.1016/j.smim.2016.09.003.
17. Seman K, Abdul Manaf H, Ismail AR. Association between functional dentition with inadequate calorie intake and underweight in elderly people living in "Pondok" in Kelantan. Arch Orofac Sci. 2007;2(1):10-9.
18. Langkamp-Henken B, et al. Nutritional formula improved immune profiles of seniors living in nursing homes. J Am Geriatr Soc. 2006;54:1861-70. https://doi.org/10.1111/j.1532-5415.2006.00982.x.
19. Akatsu H, et al. Enhanced vaccination effect against influenza by prebiotics in elderly patients receiving enteral nutrition. Geriatr Gerontol Int. 2016;16:205-13. https://doi.org/10.1111/ggi.12454.
20. Vidal K, et al. Immunomodulatory effects of dietary supplementation with a milk-based wolfberry formulation in healthy elderly: a randomized, double-blind, placebo-controlled trial. Rejuvenation Res. 2012;15:89-97. https://doi.org/10.1089/rej.2011.1241.
21. Girodon F, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN VIT AOX Geriatr Netw Arch Intern Med. 1999;159:748-54.
22. Freeman SL, et al. Dairy proteins and the response to pneumovax in senior citizens: a randomized, double-blind, placebo-controlled pilot study. Ann N Y Acad Sci. 2010;1190:97-103. https://doi.org/10.1111/j.1749-6632.2009.05264.x.
23. Moriguti JC, Ferriolli E, Donadi EA, Marchini JS. Effects of arginine supplementation on the humoral and innate immune response of older people. Eur J Clin Nutr. 2005;59:1362-6. https://doi.org/10.1038/sj.ejcn.1602247.
24. Pae M, Meydani SN, Wu D. The role of nutrition in enhancing immunity in aging. Aging Dis. 2012;3:91-129.
25. Braga CB, et al. Effect of zinc supplementation on serological response to vaccination against streptococcus Pneumoniae in patients undergoing chemotherapy for colorectal cancer. Nutr Cancer. 2015;67:926-32. https://doi.org/10.1080/01635581.2015.1053497.
26. Lang PO, Aspinall R. Vitamin D status and the host resistance to infections: what it is currently (not) understood. Clin Ther. 2017;39:930-45. https://doi.org/10.1016/j.clinthera.2017.04.004.
27. Keating R, et al. The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus. Nat Immunol. 2013;14:1266-76. https://doi.org/10.1038/ni.2741.
28. Mannick, J. B. et al. mTOR inhibition improves immune function in the elderly. Science translational medicine 6, 268ra179, https://doi.org/10.1126/scitranslmed.3009892 (2014).
29. Lefebvre JS, Haynes L. Vaccine strategies to enhance immune responses in the aged. Curr Opin Immunol. 2013;25:523-8. https://doi.org/10.1016/j.coi.2013.05.014.
30. Cunningham AL, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375:1019-32. https://doi.org/10.1056/NEJMoa1603800.
31. Levin MJ. Immune senescence and vaccines to prevent herpes zoster in older persons. Curr Opin Immunol. 2012;24:494-500. https://doi.org/10.1016/j.coi.2012.06.002.
32. Stowe RP, et al. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol. 2007;42:563-70. https://doi.org/10.1016/j.exger.2007.01.005.
33. Cobbold M, et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med. 2005;202:379-86. https://doi.org/10.1084/jem.20040613.
34. Neuenhahn, M. et al. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 31, 2161-2171, https://doi.org/10.1038/leu.2017.16 (2017).
35. Dave H, et al. Toward a rapid production of multivirus-specific T cells targeting BKV, adenovirus, CMV, and EBV from umbilical cord blood. Mol Ther Methods Clin Dev. 2017;5:13-21. https://doi.org/10.1016/j.omtm.2017.02.001.
36. Loffredo FS, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013;153:828-39. https://doi.org/10.1016/j.cell.2013.04.015.
37. Villeda SA, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med. 2014;20:659-63. https://doi.org/10.1038/nm.3569.
38. Davies J, Pulko V, Thompson H, Nikolich-Zugich J. Hetero.Chronic parabiosis: allowing the dissection of the aged immune system. J Immunol. 2015;194:1.
39. Pishel I, et al. Accelerated aging versus rejuvenation of the immune system in heterochronic parabiosis. Rejuvenation Res. 2012;15:239-48. https://doi.org/10.1089/rej.2012.1331.
40. Huestis D, Alexander W. Bogdanov: the forgotten pioneer of blood transfusion. Transfus Med Rev. 2007;21:337-40. https://doi.org/10.1016/j.tmrv.2007.05.008.
41. Aspinall R, Govind S, Lapenna A, Lang PO. Dose response kinetics of CD8 lymphocytes from young animals transfused into old animals and challenged with influenza. Immun Ageing: I & A. 2013;10:34. https://doi.org/10.1186/1742-4933-10-34.
42. Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 2011;11:330-42. https://doi.org/10.1038/nri2970.
43. Andrew D, Aspinall R. Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J Immunol. 2001;166:1524-30.
44. Muegge K, Vila MP, Durum SK. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science. 1993;261:93-5.
45. Lundstrom W, Fewkes NM, Mackall CL. IL-7 in human health and disease. Semin Immunol. 2012;24:218-24. https://doi.org/10.1016/j.smim.2012.02.005.
46. Fry TJ, Mackall CL. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol. 2005;174:6571-6.
47. Bhatia SK, Tygrett LT, Grabstein KH, Waldschmidt TJ. The effect of in vivo IL-7 deprivation on T cell maturation. J Exp Med. 1995;181:1399-409.
48. Henson SM, Snelgrove R, Hussell T, Wells DJ, Aspinall R. An IL-7 fusion protein that shows increased thymopoietic ability. J Immunol. 2005;175:4112-8.
49. El Kassar N, et al. A dose effect of IL-7 on thymocyte development. Blood. 2004;104:1419-27. https://doi.org/10.1182/blood-2004-01-0201.
50. El-Kassar N, et al. High levels of IL-7 cause dysregulation of thymocyte development. Int Immunol. 2012;24:661-71. https://doi.org/10.1093/intimm/dxs067.
51. Aspinall R, et al. Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Res. 2007;10:5-17. https://doi.org/10.1089/rej.2006.9098.
52. Rosenberg SA, et al. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother. 2006;29:313-9. https://doi.org/10.1097/01.cji.0000210386.55951.c2.
53. Tredan O, et al. ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients. Ann Oncol. 2015;26:1353-62. https://doi.org/10.1093/annonc/mdv173.
54. Goldberg GL, et al. Sex steroid ablation enhances lymphoid recovery following autologous hematopoietic stem cell transplantation. Transplantation. 2005;80:1604-13.
55. Heng TS, et al. Effects of castration on thymocyte development in two different models of thymic involution. J Immunol. 2005;175:2982-93.
56. Min H, Montecino-Rodriguez E, Dorshkind K. Reassessing the role of growth hormone and sex steroids in thymic involution. Clin Immunol. 2006;118:117-23. https://doi.org/10.1016/j.clim.2005.08.015.
57. Greenstein BD, Fitzpatrick FT, Kendall MD, Wheeler MJ. Regeneration of the thymus in old male rats treated with a stable analogue of LHRH. J Endocrinol. 1987;112:345-50.
58. Scalea JR, et al. The rejuvenating effects of leuprolide acetate on the aged baboon's thymus. Transpl Immunol. 2014;31:134-9. https://doi.org/10.1016/j.trim.2014.09.001.
59. Velardi E, et al. Sex steroid blockade enhances thymopoiesis by modulating notch signaling. J Exp Med. 2014;211:2341-9. https://doi.org/10.1084/jem.20131289.
60. Velardi E, Dudakov JA, van den Brink MR. Sex steroid ablation: an immunoregenerative strategy for immunocompromised patients. Bone Marrow Transplant. 2015;50(Suppl 2):S77-81. https://doi.org/10.1038/bmt.2015.101.
61. Sutherland JS, et al. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol. 2005;175:2741-53.
62. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2(3):REVIEWS3005. Epub 2001 Mar 9.
63. Berzins SP, et al. Thymic regeneration: teaching an old immune system new tricks. Trends Mol Med. 2002;8:469-76.
64. Min D, et al. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood. 2007;109:2529-37. https://doi.org/10.1182/blood-2006-08-043794.
65. Seggewiss R, et al. Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood. 2007;110:441-9. https://doi.org/10.1182/blood-2006-12-065623.
66. Jacobson JM, et al. A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy. J Acquir Immune Defic Syndr. 2014;66:399-406. https://doi.org/10.1097/QAI.0000000000000195.
67. Benetos A, et al. Polypharmacy in the aging patient: Management of Hypertension in octogenarians. JAMA. 2015;314:170-80. https://doi.org/10.1001/jama.2015.7517.
68. Lang PO, Govind S, Aspinall R. Reversing T cell immunosenescence: why, who, and how. Age. 2013;35:609-20. https://doi.org/10.1007/s11357-012-9393-y.
69. Lang PO, et al. Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging. 2012;7:55-64. https://doi.org/10.2147/CIA.S25215.
70. Pica N, et al. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A. 2012;109:2573-8. https://doi.org/10.1073/pnas.1200039109.
71. Lang PO, Bonduelle O, Benhabiles N, Combadiere B. Prior contact with the 2000-2003 seasonal vaccines extends the 2009 pandei a/H1N1 vaccine specific immune protection to non-numoral compartments. Eur Geriatric Med. 2014;5:2.
72. Musher DM, et al. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J Infect Dis. 2010;201:516-24. https://doi.org/10.1086/649839.
73. Percival SS. Aged garlic extract modifies human immunity. J Nutr. 2016;146:433S-6S. https://doi.org/10.3945/jn.115.210427.
74. Moro-Garcia MA, et al. Oral supplementation with lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects. Age. 2013;35:1311-26. https://doi.org/10.1007/s11357-012-9434-6.
75. Akbar AN, et al. Investigation of the cutaneous response to recall antigen in humans in vivo. Clin Exp Immunol. 2013;173:163-72. https://doi.org/10.1111/cei.12107.
76. Ndumbi P, Gilbert L, Tsoukas CM. Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individuals. PLoS One. 2015;10:e0117039. https://doi.org/10.1371/journal.pone.0117039.
77. Pera A, et al. Immunosenescence: implications for response to infection and vaccination in older people. Maturitas. 2015;82:50-5. https://doi.org/10.1016/j.maturitas.2015.05.004.